The people powering British Patient Capital
Keith led the planning and establishment of the British Business Bank from January 2013 and was appointed Chief Executive Officer in December 2013.
Prior to this, Keith was a Director at UK Financial Investments (UKFI), joining in 2009 to manage the UK government’s shareholdings in Bradford & Bingley, Northern Rock and Northern Rock Asset Management. Keith joined UKFI from Banco Santander where he was a Director of Sovereign Bancorp in the US.
He was previously Director of Strategy and Planning at Abbey National and a member of the Executive Committee and served as Chairman of Santander’s Asset Management and Credit Card businesses in the UK. Before joining Abbey in 2004, Keith spent 18 years at LEK Consulting, where he was a partner specialising in financial services.
Catherine Lewis La Torre
Catherine is CEO of British Business Investments (BBI), the commercial arm of the British Business Bank, the UK’s National Development Bank. BBI has made in excess of £2 billion of commitments to date in a large number of private debt and Venture Capital funds.
Prior to joining BBI in 2016, Catherine was Head of Private Equity at Cardano Risk Management, a pensions consultant with £120 billion of capital under advice, where she managed a global portfolio of private capital investments. Catherine has 20 years of experience as an investor in private equity funds and companies and was one of the Founding Partners of Proventure, a venture and growth capital-focussed fund manager, which invested on behalf of Nordic institutions.
Catherine also established her own private equity consultancy business advising US investors on their European private equity strategies. Catherine has lived and worked in several European countries but initiated her private equity career in London as an investment manager with Cinven, the European buyout group. Catherine has a B.Sc. (Econ) from the London School of Economics where she graduated with First Class Honours.
Russ Cummings joined British Patient Capital as an independent Non-Executive Director in June 2018.
Russ is the former Chief Executive Officer of Touchstone Innovations plc, one of the UK’s leading technology investment companies, championing outstanding science by commercialising innovative research from UK universities. Russ joined as Chief Investment Officer in 2006, then became CEO in 2013 through to the acquisition of Touchstone in 2017 by IP Group plc for £500m.
From 2003 to 2006, he was a director at the growth equity and venture capital firm, Scottish Equity Partners LLP and prior to this, spent 16 years at the international venture capital and private equity company, 3i Group plc, latterly as Director in its UK Technology Group. Russ is also a Non-Executive Director of Circassia Pharmaceuticals plc.
He holds a BSc(Eng) in Mechanical Engineering from Imperial College, London.
Managing Director, Funds
Ian manages the Funds activity of British Patient Capital. He is responsible for developing British Patient Capital’s investment strategy and investment process, as well as supervising all investment transactions – especially at the advanced due diligence stage and legal completion.
Ian joined British Patient Capital from the British Business Bank which he joined at its formation in late 2014. Prior to that Ian was part of the Bank’s predecessor, Capital for Enterprise Ltd. He brings with him a wealth of experience, including close involvement in the development of the Venture Capital Catalyst and Enterprise Capital Fund portfolios which have invested in 41 funds to date, facilitating more than £1bn of investment to more than 400 smaller businesses.